Related references
Note: Only part of the references are listed.Predictive Role of Computed Tomography Texture Analysis in Patients with Metastatic Urothelial Cancer Treated with Programmed Death-1 and Programmed Death-ligand 1 Inhibitors
Francesco Alessandrino et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET-CT
Antonia Dirnitrakopoulou-Strauss
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
S. Trebeschi et al.
ANNALS OF ONCOLOGY (2019)
Radiomics of Brain MRI: Utility in Prediction of Metastatic Tumor Type
Helge C. Kniep et al.
RADIOLOGY (2019)
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
Manpreet Sambi et al.
JOURNAL OF ONCOLOGY (2019)
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
C. Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Metabolic Biomarker-Based BRAFV600 Mutation Association and Prediction in Melanoma
Hanna Saadani et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab
Carole Durot et al.
EUROPEAN RADIOLOGY (2019)
Melanoma: Where we are and where we go
Ali Mohammadpour et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Immune-related tumour response assessment criteria: a comprehensive review
Bhanusupriya Somarouthu et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT
Christos Sachpekidis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Classifying brain metastases by their primary site of origin using a radiomics approach based on texture analysis: a feasibility study
Rafael Ortiz-Ramon et al.
EUROPEAN RADIOLOGY (2018)
Liquid biopsy to monitor melanoma patients
Maria Rita Gaiser et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2018)
Cell death-based treatments of melanoma: conventional treatments and new therapeutic strategies
Gianfranco Mattia et al.
CELL DEATH & DISEASE (2018)
Biomarkers for Clinical Benefit of immune Checkpoint inhibitor Treatment-A Review From the Melanoma Perspective and Beyond
Kristina Buder-Bakhaya et al.
FRONTIERS IN IMMUNOLOGY (2018)
Biomarkers for immune Checkpoint inhibitors in Melanoma
Shigehisa Kitano et al.
FRONTIERS IN ONCOLOGY (2018)
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
Roger Sun et al.
LANCET ONCOLOGY (2018)
Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative 18F-FDG PET/CT analysis
Ellen C. de Heer et al.
EJNMMI RESEARCH (2018)
Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review
Alessandro Stecco et al.
DIAGNOSTICS (2018)
Correlation Between SUVmax and CT Radiomic Analysis Using Lymph Node Density in PET/CT-Based Lymph Node Staging
Frederik L. Giesel et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Radiomics: the bridge between medical imaging and personalized medicine
Philippe Lambin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Malignantmelanoma. Current status
J. K. Winkler et al.
RADIOLOGE (2017)
Intratumor and Intertumor Heterogeneity in Melanoma
Tomasz M. Grzywa et al.
TRANSLATIONAL ONCOLOGY (2017)
Use of cytological samples of metastatic melanoma for ancillary studies
H. M. Ko et al.
CYTOPATHOLOGY (2017)
Problems, challenges and promises: perspectives on precision medicine
David J. Duffy
BRIEFINGS IN BIOINFORMATICS (2016)
RECIST 1.1-Update and clarification: From the RECIST committee
Lawrence H. Schwartz et al.
EUROPEAN JOURNAL OF CANCER (2016)
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies et al.
RADIOLOGY (2016)
Predicting Overall Survival in Patients With Metastatic Melanoma on Antiangiogenic Therapy and RECIST Stable Disease on Initial Posttherapy Images Using CT Texture Analysis
Andrew D. Smith et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2015)
A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities
M. Vallieres et al.
PHYSICS IN MEDICINE AND BIOLOGY (2015)
Nivolumab in melanoma: latest evidence and clinical potential
Douglas B. Johnson et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
Machine Learning methods for Quantitative Radiomic Biomarkers
Chintan Parmar et al.
SCIENTIFIC REPORTS (2015)
Clinical and Prognostic Factors for Melanoma of the Skin Using SEER Registries: Collaborative Stage Data Collection System, Version 1 and Version 2
Carol L. Kosary et al.
CANCER (2014)
Latest Advances in Chemotherapeutic, Targeted, and Immune Approaches in the Treatment of Metastatic Melanoma
Darshil J. Shah et al.
MAYO CLINIC PROCEEDINGS (2014)
Response Criteria in Oncologic Imaging: Review of Traditional and New Criteria
Temel Tirkes et al.
RADIOGRAPHICS (2013)
Assessment of Primary Colorectal Cancer Heterogeneity by Using Whole-Tumor Texture Analysis: Contrast-enhanced CT Texture as a Biomarker of 5-year Survival
Francesca Ng et al.
RADIOLOGY (2013)
Locally Advanced Squamous Cell Carcinoma of the Head and Neck: CT Texture and Histogram Analysis Allow Independent Prediction of Overall Survival in Patients Treated with Induction Chemotherapy
Haowei Zhang et al.
RADIOLOGY (2013)
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Suzanne L. Topalian et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival
Balaji Ganeshan et al.
EUROPEAN RADIOLOGY (2012)
When Progressive Disease Does Not Mean Treatment Failure: Reconsidering the Criteria for Progression
Geoffrey R. Oxnard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti-CTLA-4 Antibody Therapy
Yulia Bronstein et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
New drugs in melanoma: It's a whole new world
Alexander M. M. Eggermont et al.
EUROPEAN JOURNAL OF CANCER (2011)
Comparison of the diagnostic accuracy of whole-body MRI and whole-body CT in stage III/IV malignant melanoma
Daniel Hausmann et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2011)
Contemporary Diagnostic Imaging Modalities for the Staging and Surveillance of Melanoma Patients: a Meta-analysis
Yan Xing et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Advanced Segmentation Techniques for Lung Nodules, Liver Metastases, and Enlarged Lymph Nodes in CT Scans
Jan Hendrik Moltz et al.
IEEE JOURNAL OF SELECTED TOPICS IN SIGNAL PROCESSING (2009)
Share Paper
